首页 > 最新文献

Annals of HPB Surgery最新文献

英文 中文
Gastric stasis following pancreatoduodenal resection: terminology and prevention issues 胰十二指肠切除术后胃淤滞:术语和预防问题
Q4 Medicine Pub Date : 2022-09-20 DOI: 10.16931/1995-5464.2022-3-100-107
M. N. Kaminskiy, S. N. Kachalov, D. Ivanov, S. N. Rakhimova
Gastric stasis constitutes a common complication of pancreaticoduodenal resection, which is insufficiently covered in Russian literature. The paper considers issues pertaining to terminology and the current classification of gastric stasis. The possibilities of preventing this complication are discussed from the perspective of evidence-based medicine.
胃淤滞是胰十二指肠切除术的常见并发症,俄罗斯文献对此报道不足。本文讨论了胃淤滞的术语和目前的分类问题。从循证医学的角度讨论了预防这种并发症的可能性。
{"title":"Gastric stasis following pancreatoduodenal resection: terminology and prevention issues","authors":"M. N. Kaminskiy, S. N. Kachalov, D. Ivanov, S. N. Rakhimova","doi":"10.16931/1995-5464.2022-3-100-107","DOIUrl":"https://doi.org/10.16931/1995-5464.2022-3-100-107","url":null,"abstract":"Gastric stasis constitutes a common complication of pancreaticoduodenal resection, which is insufficiently covered in Russian literature. The paper considers issues pertaining to terminology and the current classification of gastric stasis. The possibilities of preventing this complication are discussed from the perspective of evidence-based medicine.","PeriodicalId":36549,"journal":{"name":"Annals of HPB Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44795814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transfistula cholangioscopy: clarification of the diagnosis and antegrade removal of residual bile duct stones 经峡部胆管镜检查:明确残留胆管结石的诊断和顺行清除
Q4 Medicine Pub Date : 2022-09-20 DOI: 10.16931/1995-5464.2022-3-74-80
A. D. Kovalevskii, M. Prudkov
Aim. To demonstrate our own experience of performing transfistula cholangioscopy and removing bile duct stones.Materials and Methods. From 2017 to 2019, 230 patients with functioning external biliary drains underwent antegrade transfistula cholangioscopy. Preliminary dilatation and straightening of the fistulous tract were required in 37 patients.Results. Bile duct stones were detected in 158 (68.7%) patients. During transfistula cholangioscopy, stones were removed from all patients. In 68 cases with large choledocholithiasis, it was necessary to perform contact lithotripsy. To this end, staged treatment and two hospitalizations were required in five cases. Adequate transfistular access to the bile ducts was formed during the first hospital stay; during the second, after hardening of the access walls, the stones were removed. The overall complication rate was 3.8%, including grade III–IV complications (1.9%) according to the Clavien–Dindo classification. Mortality was 0.4%.Conclusion. Transfistula cholangioscopy increases the reliability of stone detection in the bile ducts, permits removing them without mandatory dissection of the major duodenal papilla, and creates favorable conditions for a more accurate assessment of its functional state. When patients with functioning biliary drains and unresolved bile duct diseases are placed in a specialized medical center, they can be provided with high-quality care. Additionally, it creates rational conditions for the use of the highly effective methods of endobiliary diagnosis and treatment.
目标展示我们自己进行穿刺胆道镜检查和清除胆管结石的经验。材料和方法。2017年至2019年,230名有功能性外胆管引流管的患者接受了顺行穿刺胆道镜检查。37名患者需要对瘘管进行初步扩张和矫正。后果158例(68.7%)患者发现胆管结石。在穿刺胆道镜检查期间,所有患者的结石均被清除。68例大面积胆总管结石需要行接触式碎石术。为此,需要对5例患者进行分期治疗和两次住院治疗。在第一次住院期间,形成了足够的穿透胆管通道;第二次,在通道墙硬化后,石头被移走。根据Clavien-Dindo分类,总并发症发生率为3.8%,包括III–IV级并发症(1.9%)。死亡率为0.4%。结论:经峡部胆管镜检查提高了胆管结石检测的可靠性,可以在不必解剖十二指肠大乳头的情况下切除胆管,并为更准确地评估其功能状态创造了有利条件。当有功能性胆管引流管和未解决胆管疾病的患者被安置在专业医疗中心时,他们可以得到高质量的护理。此外,它为使用高效的胆道内诊断和治疗方法创造了合理的条件。
{"title":"Transfistula cholangioscopy: clarification of the diagnosis and antegrade removal of residual bile duct stones","authors":"A. D. Kovalevskii, M. Prudkov","doi":"10.16931/1995-5464.2022-3-74-80","DOIUrl":"https://doi.org/10.16931/1995-5464.2022-3-74-80","url":null,"abstract":"Aim. To demonstrate our own experience of performing transfistula cholangioscopy and removing bile duct stones.Materials and Methods. From 2017 to 2019, 230 patients with functioning external biliary drains underwent antegrade transfistula cholangioscopy. Preliminary dilatation and straightening of the fistulous tract were required in 37 patients.Results. Bile duct stones were detected in 158 (68.7%) patients. During transfistula cholangioscopy, stones were removed from all patients. In 68 cases with large choledocholithiasis, it was necessary to perform contact lithotripsy. To this end, staged treatment and two hospitalizations were required in five cases. Adequate transfistular access to the bile ducts was formed during the first hospital stay; during the second, after hardening of the access walls, the stones were removed. The overall complication rate was 3.8%, including grade III–IV complications (1.9%) according to the Clavien–Dindo classification. Mortality was 0.4%.Conclusion. Transfistula cholangioscopy increases the reliability of stone detection in the bile ducts, permits removing them without mandatory dissection of the major duodenal papilla, and creates favorable conditions for a more accurate assessment of its functional state. When patients with functioning biliary drains and unresolved bile duct diseases are placed in a specialized medical center, they can be provided with high-quality care. Additionally, it creates rational conditions for the use of the highly effective methods of endobiliary diagnosis and treatment.","PeriodicalId":36549,"journal":{"name":"Annals of HPB Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47054545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Distal resection for pancreatic tumors 胰腺肿瘤远端切除术
Q4 Medicine Pub Date : 2022-09-20 DOI: 10.16931/1995-5464.2022-3-55-62
A. Kriger, D. Gorin, A. Pavlov, N. Pronin, D. Sidorov, A. Kaldarov, K. E. Ponezhev, V. Panteleev
Aim. To study the specific features of the splenic artery architectonics and evaluate the results of distal pancreatic resection for various tumors.Materials and Methods. In the anatomical part, we examined 88 organ complexes taken from people whose death was not associated with diseases of the abdominal organs. We studied the topography of the splenic artery and the dependence of the number of its branches to the pancreas on the vessel tortuosity. The clinical part of the study presents the results of 122 distal resections performed during 2016-2021. 79 operations were carried out using the traditional method, 32 operations were robot-assisted, and 11 were performed laparoscopically.Results. The research found a relationship between the degree of the splenic artery tortuosity and the number of branches to the pancreas, which varies from three to nine. Out of the 122 operated patients, in 24 (19.7%) cases a clinically relevant (type B) pancreatic fistula that required additional treatment was formed. Intra-abdominal bleeding developed in 15 (12.3%) patients: early – in 10, late arrosive hemorrhage associated with a pancreatic fistula – in 5 cases. One (0.8%) patient died.Conclusion. It is necessary to consider the architectonics of the splenic artery during distal pancreatic resection. The frequency of pancreatic fistula formation does not depend on the method of performing the operation. Of the prognostic factors, the body mass index is statistically significant. Late arrosive bleeding develops against the background of a clinically relevant pancreatic fistula.
目标研究脾动脉结构的特点,评价胰腺远端切除治疗各种肿瘤的效果。材料和方法。在解剖部分,我们检查了88个器官复合体,这些复合体取自那些死亡与腹部器官疾病无关的人。我们研究了脾动脉的地形图,以及其通往胰腺的分支数量对血管弯曲度的依赖性。该研究的临床部分介绍了2016-2021年间进行的122次远端切除的结果。采用传统方法进行79例手术,机器人辅助32例,腹腔镜手术11例。后果研究发现,脾动脉弯曲程度与胰腺分支数量之间存在关系,胰腺分支数量从3到9不等。在122例手术患者中,有24例(19.7%)形成了需要额外治疗的临床相关(B型)胰瘘。15例(12.3%)患者出现腹腔内出血:10例早期,5例晚期与胰瘘相关的傲慢出血。一名(0.8%)患者死亡。结论在胰腺远端切除术中,有必要考虑脾动脉的结构。胰瘘形成的频率并不取决于手术的方法。在预后因素中,体重指数具有统计学意义。晚期傲慢性出血是在临床相关胰瘘的背景下发展起来的。
{"title":"Distal resection for pancreatic tumors","authors":"A. Kriger, D. Gorin, A. Pavlov, N. Pronin, D. Sidorov, A. Kaldarov, K. E. Ponezhev, V. Panteleev","doi":"10.16931/1995-5464.2022-3-55-62","DOIUrl":"https://doi.org/10.16931/1995-5464.2022-3-55-62","url":null,"abstract":"Aim. To study the specific features of the splenic artery architectonics and evaluate the results of distal pancreatic resection for various tumors.Materials and Methods. In the anatomical part, we examined 88 organ complexes taken from people whose death was not associated with diseases of the abdominal organs. We studied the topography of the splenic artery and the dependence of the number of its branches to the pancreas on the vessel tortuosity. The clinical part of the study presents the results of 122 distal resections performed during 2016-2021. 79 operations were carried out using the traditional method, 32 operations were robot-assisted, and 11 were performed laparoscopically.Results. The research found a relationship between the degree of the splenic artery tortuosity and the number of branches to the pancreas, which varies from three to nine. Out of the 122 operated patients, in 24 (19.7%) cases a clinically relevant (type B) pancreatic fistula that required additional treatment was formed. Intra-abdominal bleeding developed in 15 (12.3%) patients: early – in 10, late arrosive hemorrhage associated with a pancreatic fistula – in 5 cases. One (0.8%) patient died.Conclusion. It is necessary to consider the architectonics of the splenic artery during distal pancreatic resection. The frequency of pancreatic fistula formation does not depend on the method of performing the operation. Of the prognostic factors, the body mass index is statistically significant. Late arrosive bleeding develops against the background of a clinically relevant pancreatic fistula.","PeriodicalId":36549,"journal":{"name":"Annals of HPB Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49448035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of severe postoperative complications in pancreatic surgery using the Preoperative Pancreatic Resection (PREPARE) score: a single-center observational study 使用术前胰腺切除术(PREPARE)评分预测胰腺手术严重术后并发症:一项单中心观察性研究
Q4 Medicine Pub Date : 2022-09-20 DOI: 10.16931/1995-5464.2022-3-68-73
N. Burlov, G. Khrykov, E. A. Burlova, K. Shostka
Aim. To evaluate the effectiveness of the PREPARE score in predicting severe complications after pancreatic surgery.Materials and Methods. The case-control study included patients operated on the pancreas. Grade ≥III Clavien– Dindo complications were designated as “severe”. Patients were divided into two groups: “0–II degree” (control) and “III–V degree” (case). For all patients, scores were calculated, and risk categories were determined according to the PREPARE score.Results. The study included 151 patients: “0–II degree” – 102 (68%) observations, “III–V degree” – 49 (32%). ROC analysis was used for the scores (AUC = 0.616; 95% CI 0.527–0.706; p = 0.014) and for the risk categories (AUC = 0.555; 95% CI 0.463–0.648; p = 0.241) of the PREPARE score.Conclusion. The obtained data do not currently enable us to recommend the PREPARE score for predicting complications of pancreatic surgery.
的目标。目的:评价PREPARE评分预测胰腺手术后严重并发症的有效性。材料与方法。病例对照研究包括胰腺手术的患者。≥III级Clavien - Dindo并发症为“严重”。患者分为“0-II度”组(对照)和“III-V度”组(病例)。对所有患者计算评分,并根据PREPARE评分确定风险类别。该研究包括151例患者:“0-II度”- 102例(68%),“III-V度”- 49例(32%)。采用ROC分析(AUC = 0.616;95% ci 0.527-0.706;p = 0.014),风险类别(AUC = 0.555;95% ci 0.463-0.648;p = 0.241)。目前获得的数据不能使我们推荐PREPARE评分来预测胰腺手术并发症。
{"title":"Prediction of severe postoperative complications in pancreatic surgery using the Preoperative Pancreatic Resection (PREPARE) score: a single-center observational study","authors":"N. Burlov, G. Khrykov, E. A. Burlova, K. Shostka","doi":"10.16931/1995-5464.2022-3-68-73","DOIUrl":"https://doi.org/10.16931/1995-5464.2022-3-68-73","url":null,"abstract":"Aim. To evaluate the effectiveness of the PREPARE score in predicting severe complications after pancreatic surgery.Materials and Methods. The case-control study included patients operated on the pancreas. Grade ≥III Clavien– Dindo complications were designated as “severe”. Patients were divided into two groups: “0–II degree” (control) and “III–V degree” (case). For all patients, scores were calculated, and risk categories were determined according to the PREPARE score.Results. The study included 151 patients: “0–II degree” – 102 (68%) observations, “III–V degree” – 49 (32%). ROC analysis was used for the scores (AUC = 0.616; 95% CI 0.527–0.706; p = 0.014) and for the risk categories (AUC = 0.555; 95% CI 0.463–0.648; p = 0.241) of the PREPARE score.Conclusion. The obtained data do not currently enable us to recommend the PREPARE score for predicting complications of pancreatic surgery.","PeriodicalId":36549,"journal":{"name":"Annals of HPB Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44878193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Energetic insufficiency of liver tissue and additional energy in digital value. (The hypothesis) 肝组织的能量不足和数字价值的额外能量。(假设)
Q4 Medicine Pub Date : 2022-09-15 DOI: 10.16931/1995-5464.2022-3-114-125
E. Galperin
Despite the deep understanding of the importance of energy supply in the development of the vast majority of processes and phenomena in organism, there are practically no conceptual researches of energy requirements in severe diseases, traumatic injuries, stressful effects and related treatment in the medical literature.The proposed hypothesis is based on the analysis of literature data (PubMed keywords: energy deficit, stressor, metabolic stress, ATP, gluconeogenesis, oxidative phosphorylation, mitochondria, insulin secretion), reconsideration of the results of our experiments dedicated to the energetic statement of liver tissue in obstructive jaundice (OJ), ischemia and massive resection, summarization of 60 years of experience in clinical, surgical and scientific activities, which made it possible to make a number of assumptions that need further clinical and experimental verification.Various pathogens (stressors) cause the additional energy production in the body, which is the energy basis of metabolic responses that ensure the adaptation of the body's vital functions and the elimination of the pathogen by activation of innate immunity, systemic inflammatory reaction, activation of the sympathetic nervous system, etc.Additional energy is the integral strength of the response to the pathogen, that takes into consideration with the strength of the stressor and the individual strength of the body's response, which can be different for the same strength of the stressor. In fact, when stress develops, it determines its strength in digital form, i.e. in real view.The concept of this hypothesis comes from the fact that stress, which main task is to provide the energy of organism, appears when there is a certain level of energy deficiency in the body.Such level rarely appears immediately after the action of the stressor. At the beginning, pre-stress adaptive reactions usually occur, which use the energy reserve in cells in the form of ATP and glycogen, and are also the result of energy redistribution: a decrease in it in insulin-dependent tissues and an increase in insulin-independent ones, which include vital organs.This made it possible to divide metabolic responses into two groups: pre-stress and stress, and to distinguish two periods: “pre-stress” and “metabolic stress”. Pre-stress reactions, in our opinion, are also aimed at preventing the development of metabolic stress, which generates energy through proteolysis and lipolysis of body tissues. Metabolic stress develops when pre-stress reactions cannot satisfy the needs of the body and a certain, expressed in numerical value, energy deficit occurs. In a certain extent the metabolic situation in the body reflects by the liver, which is a metabolic organ that performs many reactions both during normal and stressful metabolism, generates ATP energy, and takes into account the metabolic state of other organs. The level of energy deficiency of the liver tissue can be an indicator that causes the form
尽管人们深刻认识到能量供应在生物体绝大多数过程和现象发展中的重要性,但在医学文献中,几乎没有关于严重疾病、创伤性损伤、应激效应和相关治疗中能量需求的概念性研究。提出的假设是基于对文献数据的分析(PubMed关键词:能量不足,应激源,代谢应激,ATP,糖异生,氧化磷酸化,线粒体,胰岛素分泌),重新考虑我们致力于梗阻性黄疸(OJ)中肝组织能量陈述的实验结果,缺血和大面积切除,总结60年的临床,外科和科学活动经验,这使得有可能做出一些需要进一步临床和实验验证的假设。各种病原体(应激源)在体内产生额外的能量,这是代谢反应的能量基础,通过激活先天免疫、全身炎症反应、激活交感神经系统等,确保机体重要功能的适应和消除病原体。额外的能量是对病原体反应的整体强度。这要考虑到压力源的强度和个体身体反应的强度,对于相同强度的压力源,它们可能是不同的。事实上,当应力发展时,它以数字形式确定其强度,即在真实视图中。这一假说的概念来自于这样一个事实,即当身体存在一定程度的能量不足时,压力就会出现,而压力的主要任务是为生物体提供能量。这种程度很少在应激源作用后立即出现。一开始,通常会发生应激前适应反应,这是利用细胞中以ATP和糖原形式储存的能量,也是能量重新分配的结果:在胰岛素依赖性组织中,能量减少,而在包括重要器官在内的胰岛素非依赖性组织中,能量增加。这使得将代谢反应分为两组:pre-stress和stress,并区分两个时期:“pre-stress”和“metabolic stress”成为可能。我们认为,预应激反应也是为了防止代谢应激的发展,代谢应激通过身体组织的蛋白质分解和脂肪分解产生能量。当预应激反应不能满足身体的需要,并出现一定的,以数值表示的能量赤字时,代谢应激就产生了。肝脏在一定程度上反映了机体的代谢状况,肝脏是一个代谢器官,在正常代谢和应激代谢过程中都进行多种反应,产生ATP能量,并兼顾其他器官的代谢状态。肝组织能量不足水平可以作为引起代谢应激形成的一个指标,用数值来评价机体的能量状态,以及机体一般状况的严重程度、有希望的机会、预后和优先治疗,应以全面补充能量不足为目标。在COVID-19严重形式和低血氧饱和度的情况下,这一点尤其重要。在任何压力的影响下,医生必须解决两个问题:处理特定的压力源,并为这种斗争和病人的重要活动提供能量。弥漫性疾病中肝脏功能不全可导致糖异生或葡萄糖氧化磷酸化受损,形成“不成功”或“不完全”应激。
{"title":"Energetic insufficiency of liver tissue and additional energy in digital value. (The hypothesis)","authors":"E. Galperin","doi":"10.16931/1995-5464.2022-3-114-125","DOIUrl":"https://doi.org/10.16931/1995-5464.2022-3-114-125","url":null,"abstract":"Despite the deep understanding of the importance of energy supply in the development of the vast majority of processes and phenomena in organism, there are practically no conceptual researches of energy requirements in severe diseases, traumatic injuries, stressful effects and related treatment in the medical literature.The proposed hypothesis is based on the analysis of literature data (PubMed keywords: energy deficit, stressor, metabolic stress, ATP, gluconeogenesis, oxidative phosphorylation, mitochondria, insulin secretion), reconsideration of the results of our experiments dedicated to the energetic statement of liver tissue in obstructive jaundice (OJ), ischemia and massive resection, summarization of 60 years of experience in clinical, surgical and scientific activities, which made it possible to make a number of assumptions that need further clinical and experimental verification.Various pathogens (stressors) cause the additional energy production in the body, which is the energy basis of metabolic responses that ensure the adaptation of the body's vital functions and the elimination of the pathogen by activation of innate immunity, systemic inflammatory reaction, activation of the sympathetic nervous system, etc.Additional energy is the integral strength of the response to the pathogen, that takes into consideration with the strength of the stressor and the individual strength of the body's response, which can be different for the same strength of the stressor. In fact, when stress develops, it determines its strength in digital form, i.e. in real view.The concept of this hypothesis comes from the fact that stress, which main task is to provide the energy of organism, appears when there is a certain level of energy deficiency in the body.Such level rarely appears immediately after the action of the stressor. At the beginning, pre-stress adaptive reactions usually occur, which use the energy reserve in cells in the form of ATP and glycogen, and are also the result of energy redistribution: a decrease in it in insulin-dependent tissues and an increase in insulin-independent ones, which include vital organs.This made it possible to divide metabolic responses into two groups: pre-stress and stress, and to distinguish two periods: “pre-stress” and “metabolic stress”. Pre-stress reactions, in our opinion, are also aimed at preventing the development of metabolic stress, which generates energy through proteolysis and lipolysis of body tissues. Metabolic stress develops when pre-stress reactions cannot satisfy the needs of the body and a certain, expressed in numerical value, energy deficit occurs. In a certain extent the metabolic situation in the body reflects by the liver, which is a metabolic organ that performs many reactions both during normal and stressful metabolism, generates ATP energy, and takes into account the metabolic state of other organs. The level of energy deficiency of the liver tissue can be an indicator that causes the form","PeriodicalId":36549,"journal":{"name":"Annals of HPB Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46541126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Results of using transfistula videoscopic necrosequestrectomy to treat purulent-necrotic parapancreatitis 应用电视透视坏死隔离切除术治疗化脓性坏死性副胰腺炎的疗效
Q4 Medicine Pub Date : 2022-06-07 DOI: 10.16931/10.16931/1995-5464.2022-2-73-81
S. Remizov, A. Andreev, V. M. Durleshter, S. A. Gabriel’, F. K. Akhidzhak
Aim. To improve the efficacy of minimally invasive surgical treatment for infected pancreatic necrosis.Materials and methods. The study analyzed the data of 142 patients with moderate to severe infected pancreatic necrosis treated from 2012 to 2017. In 2012–2014, an incision and drainage procedure involving multiple drainage replacements and debridements was used in 84 (59.2%) patients comprising Group 1. Since 2015, 58 (40.8%) patients comprising Group 2 have been treated using large-diameter (30–32 Fr) tube drainage followed by debridement and transfistula videoscopic necrosequestrectomy.Results. The best results were obtained by draining pathological cavities using large-diameter double-lumen drainage, as well as by actively removing sequestra using the developed technique of transfistula videoscopic necrosequestrectomy. In Group 2, the incidence of local complications amounted to 6.8% as compared to 22.6% in Group 1. Group 2 exhibited significantly lower case mortality rate (12.3% and 19.4%; t = 2.1; p ≤ 0.05), while patients in Group 1 required longer hospitalization: 96 ± 7.4 days as compared to 71 ± 3.2 days in Group 2 (t = 2.9 p ≤ 0.05).Conclusion. Minimally invasive procedures involving transfistula videoscopic necrosequestrectomy improve treatment outcomes, as well as reducing case mortality rate in the setting of purulent-necrotic parapancreatitis.
目标提高微创手术治疗感染性胰腺坏死的疗效。材料和方法。该研究分析了2012年至2017年接受治疗的142名中重度感染性胰腺坏死患者的数据。2012-2014年,第1组共有84名(59.2%)患者采用了包括多次引流置换和清创术在内的切开引流术。自2015年以来,第2组共有58名(40.8%)患者接受了大直径(30–32 Fr)管引流治疗,随后进行清创术和穿透stula视频坏死隔离切除术。后果使用大直径双腔引流引流病理腔,以及使用已开发的穿透stula视频坏死截骨术积极去除截骨,可获得最佳效果。第2组的局部并发症发生率为6.8%,而第1组为22.6%。第2组的病例死亡率显著降低(12.3%和19.4%;t=2.1;p≤0.05),而第1组的患者需要更长的住院时间:96±7.4天,而第2组为71±3.2天(t=2.9 p≤0.05,以及在化脓性坏死性副胰腺炎的情况下降低病例死亡率。
{"title":"Results of using transfistula videoscopic necrosequestrectomy to treat purulent-necrotic parapancreatitis","authors":"S. Remizov, A. Andreev, V. M. Durleshter, S. A. Gabriel’, F. K. Akhidzhak","doi":"10.16931/10.16931/1995-5464.2022-2-73-81","DOIUrl":"https://doi.org/10.16931/10.16931/1995-5464.2022-2-73-81","url":null,"abstract":"Aim. To improve the efficacy of minimally invasive surgical treatment for infected pancreatic necrosis.Materials and methods. The study analyzed the data of 142 patients with moderate to severe infected pancreatic necrosis treated from 2012 to 2017. In 2012–2014, an incision and drainage procedure involving multiple drainage replacements and debridements was used in 84 (59.2%) patients comprising Group 1. Since 2015, 58 (40.8%) patients comprising Group 2 have been treated using large-diameter (30–32 Fr) tube drainage followed by debridement and transfistula videoscopic necrosequestrectomy.Results. The best results were obtained by draining pathological cavities using large-diameter double-lumen drainage, as well as by actively removing sequestra using the developed technique of transfistula videoscopic necrosequestrectomy. In Group 2, the incidence of local complications amounted to 6.8% as compared to 22.6% in Group 1. Group 2 exhibited significantly lower case mortality rate (12.3% and 19.4%; t = 2.1; p ≤ 0.05), while patients in Group 1 required longer hospitalization: 96 ± 7.4 days as compared to 71 ± 3.2 days in Group 2 (t = 2.9 p ≤ 0.05).Conclusion. Minimally invasive procedures involving transfistula videoscopic necrosequestrectomy improve treatment outcomes, as well as reducing case mortality rate in the setting of purulent-necrotic parapancreatitis.","PeriodicalId":36549,"journal":{"name":"Annals of HPB Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49457781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrent thrombosis of liver transplant artery: diagnosis and staged minimally invasive treatment 肝移植动脉复发性血栓的诊断及分期微创治疗
Q4 Medicine Pub Date : 2022-06-07 DOI: 10.16931/1995-5464.2022-2-108-114
S. Grigorev, A. V. Novozhilov, E. G. Grygoryev
The paper presents a clinical study of a 53-year-old patient who underwent liver transplantation complicated by proper hepatic artery thrombosis. No clinical or laboratory signs of the complication were observed. The disruption of arterial blood supply to the transplant was established on day six following surgery by means of routine Doppler ultrasound. Following successful selective endovascular thrombus aspiration and balloon dilation, the arterial blood flow was restored. However, one day later, the thrombosis recurred. Hepatic revascularization was achieved through thrombus re-aspiration and the proper hepatic artery stenting. In the subsequent postoperative period, no complications were observed. The paper analyzes possible causes of thrombosis and recurrent thrombosis, as well as reviewing modern literature.
本文报道一例53岁肝移植患者并发肝固有动脉血栓形成的临床研究。未观察到并发症的临床或实验室体征。术后第6天通过常规多普勒超声检查确定移植动脉供血中断。在选择性血管内血栓抽吸和球囊扩张成功后,动脉血流恢复。然而,一天后,血栓又复发了。肝血运重建术是通过血栓再抽吸和肝动脉支架植入术实现的。术后未见并发症发生。本文分析了血栓形成和复发性血栓形成的可能原因,并对现代文献进行了综述。
{"title":"Recurrent thrombosis of liver transplant artery: diagnosis and staged minimally invasive treatment","authors":"S. Grigorev, A. V. Novozhilov, E. G. Grygoryev","doi":"10.16931/1995-5464.2022-2-108-114","DOIUrl":"https://doi.org/10.16931/1995-5464.2022-2-108-114","url":null,"abstract":"The paper presents a clinical study of a 53-year-old patient who underwent liver transplantation complicated by proper hepatic artery thrombosis. No clinical or laboratory signs of the complication were observed. The disruption of arterial blood supply to the transplant was established on day six following surgery by means of routine Doppler ultrasound. Following successful selective endovascular thrombus aspiration and balloon dilation, the arterial blood flow was restored. However, one day later, the thrombosis recurred. Hepatic revascularization was achieved through thrombus re-aspiration and the proper hepatic artery stenting. In the subsequent postoperative period, no complications were observed. The paper analyzes possible causes of thrombosis and recurrent thrombosis, as well as reviewing modern literature.","PeriodicalId":36549,"journal":{"name":"Annals of HPB Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44058200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Difficulties in diagnosing pancreatoblastoma 胰脏母细胞瘤的诊断难点
Q4 Medicine Pub Date : 2022-06-07 DOI: 10.16931/1995-5464.2022-2-102-107
A. Kriger, N. Ratnikova, V. Panteleev, D. Gorin, A. Kaldarov, G. Karmazanovsky
Clinical observation of surgical treatment received by a patient with pancreatoblastoma is described. In the preoperative period, specialists had difficulties in determining the nature of the neoplasm, which led to some tactical complications. The patient underwent pancreaticoduodenal resection that involved resection of the pancreatic body, as well as the confluence of the superior mesenteric and splenic veins. The histologic and immunohistochemical studies confirmed the diagnosis of pancreatoblastoma. Therefore, the patient was referred for chemotherapeutic treatment.
本文报道一例胰母细胞瘤手术治疗的临床观察。在术前,专家很难确定肿瘤的性质,这导致了一些战术并发症。患者行胰十二指肠切除术,包括胰体切除术,以及肠系膜上静脉和脾静脉的汇合处切除术。组织学和免疫组织化学检查证实了胰脏母细胞瘤的诊断。因此,患者被转介化疗。
{"title":"Difficulties in diagnosing pancreatoblastoma","authors":"A. Kriger, N. Ratnikova, V. Panteleev, D. Gorin, A. Kaldarov, G. Karmazanovsky","doi":"10.16931/1995-5464.2022-2-102-107","DOIUrl":"https://doi.org/10.16931/1995-5464.2022-2-102-107","url":null,"abstract":"Clinical observation of surgical treatment received by a patient with pancreatoblastoma is described. In the preoperative period, specialists had difficulties in determining the nature of the neoplasm, which led to some tactical complications. The patient underwent pancreaticoduodenal resection that involved resection of the pancreatic body, as well as the confluence of the superior mesenteric and splenic veins. The histologic and immunohistochemical studies confirmed the diagnosis of pancreatoblastoma. Therefore, the patient was referred for chemotherapeutic treatment.","PeriodicalId":36549,"journal":{"name":"Annals of HPB Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42231232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pancreatic stenting in the prevention and combination therapy of acute pancreatitis 胰腺支架置入术在急性胰腺炎的预防和联合治疗中的应用
Q4 Medicine Pub Date : 2022-06-07 DOI: 10.16931/1995-5464.2022-2-65-72
I. M. Buriev, S. A. Grashchenko, L. V. Zhuravleva, A. E. Kotovskii, S. O. Shadskii, D. S. Kulikov, M. V. Guk
Aim. To evaluate the efficacy of endoscopic transpapillary pancreatic stenting in the prevention and combination therapy of acute pancreatitis.Materials and methods. The study examined 166 cases of pancreatic duct stenting intended to prevent acute postprocedural pancreatitis in 105 patients and to provide a combination therapy for acute pancreatitis in 61 patients. In this case plastic stents (3–7 Fr) were used that were removed on days 3–5 provided neither amylasemia nor clinical signs of acute pancreatitis were observed.Results. Pancreatic stenting performed to prevent acute post-procedural pancreatitis in 100 patients yielded good results in 95.2% of the cases; elective surgery was performed in 16 of these cases after 2 weeks. In 3.8% of the cases, some complications were observed (pancreatitis, jaundice); one (0.95%) fatal case was reported. In the combination therapy of severe pancreatitis (APACHE II >10 points), recovery was observed in 86.9% of the cases involving pancreatic duct stenting. In 11.3% of the cases, stenting was accompanied by minimally invasive surgical procedures. The disease was found to have progressed in 12 patients (19.7%). Four patients were discharged from the hospital with pancreatic fistulas, while 8 patients (13.1%) died.Conclusion. Preventive stenting of the pancreatic duct in the setting of complicated and atypical papillosphincterotomy reduces the incidence of acute pancreatitis to 3.8% at a case fatality rate of 0.95%. Pancreatic duct stenting is indicated for treatment of pancreatic necrosis in the setting of biliary pancreatitis involving impacted stones and severe acute pancreatitis at an amylase level of > 400 U/L during the first three days of the disease.
的目标。目的探讨内镜下经乳头胰腺支架置入术在预防和联合治疗急性胰腺炎中的疗效。材料和方法。该研究检查了166例胰管支架植入术,旨在预防105例急性术后胰腺炎,并为61例急性胰腺炎患者提供联合治疗。在本病例中,使用塑料支架(3 - 7fr),在3-5天取出,没有观察到淀粉酶血症和急性胰腺炎的临床症状。100例患者行胰腺支架植入术预防急性术后胰腺炎,95.2%的患者获得良好效果;其中16例在2周后进行择期手术。3.8%的病例出现并发症(胰腺炎、黄疸);报告死亡1例(0.95%)。在重症胰腺炎(APACHEⅱbbb10分)联合治疗中,86.9%的患者胰管支架置入术后恢复。在11.3%的病例中,支架植入伴随着微创外科手术。12例(19.7%)患者发现疾病进展。4例患者因胰瘘出院,8例(13.1%)死亡。在复杂和非典型乳头括约肌切开术的情况下,预防性胰管支架植入术可将急性胰腺炎的发病率降低至3.8%,病死率为0.95%。胰管支架植入术适用于胰坏死的胆道性胰腺炎合并嵌塞结石和严重急性胰腺炎的治疗,在疾病的前三天,淀粉酶水平为bb0 400 U/L。
{"title":"Pancreatic stenting in the prevention and combination therapy of acute pancreatitis","authors":"I. M. Buriev, S. A. Grashchenko, L. V. Zhuravleva, A. E. Kotovskii, S. O. Shadskii, D. S. Kulikov, M. V. Guk","doi":"10.16931/1995-5464.2022-2-65-72","DOIUrl":"https://doi.org/10.16931/1995-5464.2022-2-65-72","url":null,"abstract":"Aim. To evaluate the efficacy of endoscopic transpapillary pancreatic stenting in the prevention and combination therapy of acute pancreatitis.Materials and methods. The study examined 166 cases of pancreatic duct stenting intended to prevent acute postprocedural pancreatitis in 105 patients and to provide a combination therapy for acute pancreatitis in 61 patients. In this case plastic stents (3–7 Fr) were used that were removed on days 3–5 provided neither amylasemia nor clinical signs of acute pancreatitis were observed.Results. Pancreatic stenting performed to prevent acute post-procedural pancreatitis in 100 patients yielded good results in 95.2% of the cases; elective surgery was performed in 16 of these cases after 2 weeks. In 3.8% of the cases, some complications were observed (pancreatitis, jaundice); one (0.95%) fatal case was reported. In the combination therapy of severe pancreatitis (APACHE II >10 points), recovery was observed in 86.9% of the cases involving pancreatic duct stenting. In 11.3% of the cases, stenting was accompanied by minimally invasive surgical procedures. The disease was found to have progressed in 12 patients (19.7%). Four patients were discharged from the hospital with pancreatic fistulas, while 8 patients (13.1%) died.Conclusion. Preventive stenting of the pancreatic duct in the setting of complicated and atypical papillosphincterotomy reduces the incidence of acute pancreatitis to 3.8% at a case fatality rate of 0.95%. Pancreatic duct stenting is indicated for treatment of pancreatic necrosis in the setting of biliary pancreatitis involving impacted stones and severe acute pancreatitis at an amylase level of > 400 U/L during the first three days of the disease.","PeriodicalId":36549,"journal":{"name":"Annals of HPB Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42020177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of different methods for preventing gastroesophageal bleeding in patients with liver cirrhosis: comparative analysis 不同方法预防肝硬化胃食管出血的疗效对比分析
Q4 Medicine Pub Date : 2022-06-07 DOI: 10.16931/1995-5464.2022-2-31-38
F. Nazyrov, A. V. Devyatov, A. Babadjanov, U. Makhmudov, O. A. Omonov
Aim. To assess the clinical efficacy of preventing gastroesophageal bleeding in patients with liver cirrhosis.Materials and methods. From 2008 to 2019, the surgical treatment of 710 patients with cirrhosis was considered. The long-term results of preventing gastroesophageal variceal rebleeding were studied in three groups of patients: portosystemic shunt placement (367 patients), total esophagogastric disconnection (62 patients), and endoscopic procedures (281 patients). Observation periods varied from 1 to 115 months.Results. The lowest rebleeding rate of 15.5% was observed following shunt placement (χ2 = 9.728; df = 2; р = 0.008), while the highest rate of 40.9% was observed following endoscopic treatment. By the 5th year of follow-up, only 37.5% of patients showed no signs of bleeding following endoscopic procedures. The percentage of patients who did not experience true gastroesophageal variceal rebleeding amounted to 44%, 76%, and 85% following shunt placement, total esophagogastric disconnection, and endoscopic procedures, respectively (p < 0.05).Conclusion. Irrespective of the selected procedure, all patients with cirrhosis suffer from portal rebleeding in the longterm period. However, the lowest rebleeding rate is observed following portosystemic shunt placement.
目标评价肝硬化患者预防胃食管出血的临床疗效。材料和方法。从2008年到2019年,考虑了710名肝硬化患者的手术治疗。对三组患者预防胃食管静脉曲张再出血的长期结果进行了研究:门体分流术(367名患者)、食管胃完全断开术(62名患者)和内镜手术(281名患者)。观察期从1个月到115个月不等。后果分流术后再出血率最低,为15.5%(χ2=9.728;df=2;р=0.008),而内镜治疗后的再出血率最高,为40.9%。到随访的第5年,只有37.5%的患者在内镜手术后没有出血迹象。在分流术、食管胃完全断开术和内镜手术后,未经历真正的胃食管静脉曲张再出血的患者比例分别为44%、76%和85%(p<0.05)。结论:无论选择何种手术,所有肝硬化患者都会长期发生门脉再出血。然而,门体分流术后再出血率最低。
{"title":"Efficacy of different methods for preventing gastroesophageal bleeding in patients with liver cirrhosis: comparative analysis","authors":"F. Nazyrov, A. V. Devyatov, A. Babadjanov, U. Makhmudov, O. A. Omonov","doi":"10.16931/1995-5464.2022-2-31-38","DOIUrl":"https://doi.org/10.16931/1995-5464.2022-2-31-38","url":null,"abstract":"Aim. To assess the clinical efficacy of preventing gastroesophageal bleeding in patients with liver cirrhosis.Materials and methods. From 2008 to 2019, the surgical treatment of 710 patients with cirrhosis was considered. The long-term results of preventing gastroesophageal variceal rebleeding were studied in three groups of patients: portosystemic shunt placement (367 patients), total esophagogastric disconnection (62 patients), and endoscopic procedures (281 patients). Observation periods varied from 1 to 115 months.Results. The lowest rebleeding rate of 15.5% was observed following shunt placement (χ2 = 9.728; df = 2; р = 0.008), while the highest rate of 40.9% was observed following endoscopic treatment. By the 5th year of follow-up, only 37.5% of patients showed no signs of bleeding following endoscopic procedures. The percentage of patients who did not experience true gastroesophageal variceal rebleeding amounted to 44%, 76%, and 85% following shunt placement, total esophagogastric disconnection, and endoscopic procedures, respectively (p < 0.05).Conclusion. Irrespective of the selected procedure, all patients with cirrhosis suffer from portal rebleeding in the longterm period. However, the lowest rebleeding rate is observed following portosystemic shunt placement.","PeriodicalId":36549,"journal":{"name":"Annals of HPB Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42134421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Annals of HPB Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1